PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 107 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2016. The put-call ratio across all filers is 20.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2019 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2019 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2019 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2019 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2018 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2017 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2017 | $0 | – | 10 | -9.1% | 0.00% | – |
Q1 2017 | $0 | – | 11 | +10.0% | 0.00% | – |
Q4 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2016 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2015 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2015 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2015 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2015 | $0 | – | 10 | 0.0% | 0.00% | – |
Q4 2014 | $0 | – | 10 | 0.0% | 0.00% | – |
Q3 2014 | $0 | – | 10 | 0.0% | 0.00% | – |
Q2 2014 | $0 | – | 10 | 0.0% | 0.00% | – |
Q1 2014 | $0 | – | 10 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
IFP Advisors, Inc | 0 | $0 | 0.00% |
NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |